Outcomes of treatment for hepatitis C virus infection by primary care providers
Publication Type:
Journal Article
Authors:
Arora, S.;
Thornton, K.;
Murata, G.;
Deming, P.;
Kalishman, S.;
Dion, D.;
Parish, B.;
Burke, T.;
Pak, W.;
Dunkelberg, J.;
Kistin, M.;
Brown, J.;
Jenkusky, S.;
Komaromy, M.;
Qualls, C.Source:
N Engl J Med, Volume 364, Issue 23, p.2199-2207 (2011)
Keywords:
Academic Medical Centers,
Adult,
Analysis of Variance,
Antiviral Agents,
chronic HCV,
Cohort Studies,
Community Health Services,
Comparative Study,
Disease,
drug effects,
drug therapy,
ECHO,
Female,
genetics,
Genotype,
genotype 1,
HCV,
Health,
Health Services Accessibility,
Hepacivirus,
hepatitis,
Hepatitis C,
hepatitis C virus,
Hepatitis C,Chronic,
Humans,
Infection,
interferon,
Interferon Alfa-2a,
Interferon-alpha,
Internal Medicine,
Male,
Medically Underserved Area,
Medicine,
methods,
Mexico,
Middle Aged,
New Mexico,
Patients,
peginterferon,
Physicians,Primary Care,
Polyethylene Glycols,
Prisons,
Prospective Studies,
Proteins,
Recombinant Proteins,
Research,
Research Support,
Rural Health Services,
sustained virologic response,
Telemedicine,
therapeutic use,
therapy,
Treatment Outcome,
Videoconferencing,
virology
